String vessel formation is increased in the brain of Parkinson disease

Journal of Parkinson's Disease

Volumn 5, Issue 4, 2015, Pages 821-836

  Yang, Panzao ^a   Pavlovic, Darja ^a   Waldvogel, Henry ^a   Dragunow, Mike ^a   Synek, Beth ^b   Turner, Clinton ^a,b   Faull, Richard ^a   Guan, Jian ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

age and human; Capillaries; Parkinsons disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; COLLAGEN TYPE 4; FIBRINOGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; TYROSINE 3 MONOOXYGENASE;

AGED; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD VESSEL PARAMETERS; BRAIN; CAPILLARY BASEMENT MEMBRANE; CAPILLARY DENSITY; CAPILLARY LENGTH; CAUDATE NUCLEUS; CELL DENSITY; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE FRONTAL GYRUS; NERVE CELL DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; STRING VESSEL FORMATION; SUBSTANTIA NIGRA; VASCULAR DISEASE; VERY ELDERLY; BASEMENT MEMBRANE; CAPILLARY; CASE CONTROL STUDY; CYTOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PREFRONTAL CORTEX; TISSUE BANK; VASCULAR ENDOTHELIUM; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ASTROCYTES; BASEMENT MEMBRANE; BLOOD-BRAIN BARRIER; CAPILLARIES; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREFRONTAL CORTEX; SUBSTANTIA NIGRA; TISSUE BANKS;

EID: 84952672719     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-140454     Document Type: Article

References (39)

1. Calne DB, Zigmond MJ, 1991 Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. Arch Neurol 48 361 363
2. Poewe W, 2009 Treatments for Parkinson disease-past achievements and current clinical needs. Neurology 72 S65 S73
3. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K, 2004 Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318 121 134
4. de la Torre JC, 2002 Alzheimer's disease: How does it start? J Alzheimers Dis 4 497 512
5. Iadecola C, 2004 Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5 347 360
6. Guan J, Pavlovic D, Dalkie N, Waldvogel HJ, O'Carroll SJ, Green CR, Nicholson LF, 2013 Vascular degeneration in Parkinson's disease. Brain Pathol 23 154 164
7. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD, 2006 Blood-brain barrier: Structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1 223 236
8. Yurchenco PD, 2011 Basement membranes: Cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol 3. pii: a004911.
9. Choi BH, 1994 Role of the basement membrane in neurogenesis and repair of injury in the central nervous system. Microsc Res Tech 28 193 203
10. Brown WR, 2010 A review of string vessels or collapsed, empty basement membrane tubes. J Alzheimers Dis 21 725 739
11. Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, Sabbagh MN, Beach TG, Roher AE, 2012 Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS One 7 e36893
12. Davila D, Thibault K, Fiacco TA, Agulhon C, 2013 Recent molecular approaches to understanding astrocyte function in vivo. Front Cell Neurosci 7 272
13. Gnanaguru G, Bachay G, Biswas S, Pinzon-Duarte G, Hunter DD, Brunken WJ, 2013 Laminins containing the beta2 and gamma3 chains regulate astrocyte migration and angiogenesis in the retina. Development 140 2050 2060
14. Thu DC, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, Luthi-Carter R, Waldvogel HJ, Faull RL, 2010 Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 133 1094 1110
15. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, 2005 Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65 1863 1872
16. Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H, 2009 Staging/typing of Lewy body related alpha-synuclein pathology: A study of the brainNet europe consortium. Acta Neuropathol 117 635 652
17. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, 2012 National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: A practical approach. Acta Neuropathol 123 1 11
18. Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, Boluda S, Bugiani O, Duyckaerts C, Gelpi E, Gentleman S, Giaccone G, Graeber M, Hortobagyi T, Hoftberger R, Ince P, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Pikkarainen M, Revesz T, Rozemuller A, Seilhean D, Schulz-Schaeffer W, Streichenberger N, Wharton SB, Kretzschmar H, 2009 Assessment of beta-amyloid deposits in human brain: A study of the brainnet euroe consortium. Acta Neuropathol 117 309 320
19. Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H, 2008 Staging of neurofibrillary pathology in Alzheimer's disease: A study of the brainNet europe consortium. Brain Pathol 18 484 496
20. Thal DR, Rub U, Orantes M, Braak H, 2002 Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58 1791 1800
21. Waldvogel HJ, Curtis MA, Baer K, Rees MI, Faull RL, 2006 Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc 1 2719 2732
22. Lin CY, Hsu YH, Lin MH, Yang TH, Chen HM, Chen YC, Hsiao HY, Chen CC, Chern Y, Chang C, 2013 Neurovascular abnormalities in humans and mice with Huntington's disease. Exp Neurol 250 20 30
23. Salhia B, Angelov L, Roncari L, Wu X, Shannon P, Guha A, Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB, 2000 Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res 883 87 97
24. Takahashi M, Macdonald RL, 2004 Vascular aspects of neuroprotection. Neurol Res 26 862 869
25. Koyama Y, Michinaga S, 2012 Regulations of astrocytic functions by endothelins: Roles in the pathophysiological responses of damaged brains. J Pharmacol Sci 118 401 407
26. Cortes-Canteli M, Zamolodchikov D, Ahn HJ, Strickland S, Norris EH, 2012 Fibrinogen and altered hemostasis in Alzheimer's disease. J Alzheimers Dis 32 599 608
27. Freitas-Andrade M, Carmeliet P, Charlebois C, Stanimirovic Db, Moreno MJ, 2012 PlGF knockout delays brain vessel growth and maturation upon systemic hypoxic challenge. J Cereb Blood Flow Metab 32 663 675
28. Freeman R, Niego B, Croucher DR, Ostergaard Pedersen L, Medcalf RL, 2014 t-PA, but not desmoteplase, induces a plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions which can be reversed within a limited time frame. Brain Res 1565 63 73
29. Ryu JK, McLarnon JG, 2009 A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med 13 2911 2925
30. Ryu JK, McLarnon JG, 2008 VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult. J Neuroinflammation 5 18
31. Hsiao TW, Swarup VP, Kuberan B, Tresco PA, Hlady V, 2013 Astrocytes specifically remove surface-adsorbed fibrinogen and locally express chondroitin sulfate proteoglycans. Acta Biomater 9 7200 7208
32. Maarouf CL, Beach TG, Adler CH, Shill HA, Sabbagh MN, Wu T, Walker DG, Kokjohn TA, Roher AE, 2012 Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects. Neurol Res 34 669 676
33. More SV, Kumar H, Kim IS, Song SY, Choi DK, 2013 Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediators Inflam 2013 952375
34. Kim YS, Joh TH, 2006 Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson's disease. Exp Mol Med 38 333 347
35. Donnan GA, Woodhouse DG, Kaczmarczyk SJ, Holder JE, Paxinos G, Chilco PJ, Churchyard AJ, Kalnins RM, Fabinyi GC, Mendelsohn FA, 1991 Evidence for plasticity of the dopaminergic system in parkinsonism. Mol Neurobiol 5 421 433
36. Apostolova LG, Beyer M, Green AE, Hwang KS, Morra JH, Chou YY, Avedissian C, Aarsland D, Janvin CC, Larsen JP, Cummings JL, Thompson PM, 2010 Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord 25 687 695
37. Waters CM, Peck R, Rossor M, Reynolds GP, Hunt SP, 1988 Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and huntington's chorea. Neuroscience 25 419 438
38. Kim KK, Adelstein RS, Kawamoto S, 2009 Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors. J Biol Chem 284 31052 31061
39. Narayanan NS, Rodnitzky RL, Uc EY, 2013 Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease. Rev Neurosci 24 267 278